Xbrane Biopharma AB (XBRANE.XSTO) Financials
All currency values in kr millions unless otherwise noted
Scroll
| Income Statement | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | kr 152 | kr 148 | kr 239 | kr 58 | kr 11 |
| Cost of Revenue | kr 63 | kr 18 | kr 203 | kr 0 | kr 0 |
| Gross Profit | kr 90 | kr 130 | kr 35 | kr 58 | kr 11 |
| Total Operating Expenses | kr 158 | kr 249 | kr 345 | kr 231 | kr 187 |
| Operating Income | -kr 68 | -kr 119 | -kr 310 | -kr 174 | -kr 176 |
| Non-Operating | |||||
| Net Interest Expense | -kr 12 | -kr 31 | -kr 19 | -kr 3 | -kr 3 |
| Income Tax Expense | kr 2 | kr 12 | kr 0 | kr 0 | kr 0 |
| Net Income | |||||
| Net Income | kr 127 | -kr 266 | -kr 388 | -kr 173 | -kr 188 |
| Per Share Data | |||||
| Revenue Per Share | kr 0.10 | kr 15.30 | kr 0.94 | kr 0.26 | kr 0.05 |
| EPS (Basic) | kr 0.08 | -kr 27.50 | -kr 1.53 | -kr 0.77 | -kr 0.90 |
| EPS (Diluted) | kr 0.08 | -kr 27.50 | -kr 1.53 | -kr 0.77 | -kr 0.90 |
| Shares Outstanding | 1.59B | 9.7M | 253.3M | 225.4M | 208.2M |
Related stocks: Biotechnology
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.